ACORDA THERAPEUTICS INC (ACOR)
US00484M7002 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.98M | 37.50M | 45.60M | 71.40M | 62.10M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 63.80M | |||
| Receivables | 17.30M | 13.90M | 17.00M | 20.20M | 22.10M | |||
| Inventories | 16.16M | 12.80M | 18.50M | 28.70M | 25.20M | |||
| Other Current Assets | 11.36M | 17.90M | 21.00M | 101.10M | 28.00M | |||
| Total Current Assets | 74.79M | 82.10M | 102.20M | 221.30M | 201.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.30M | 7.90M | 11.10M | 25.70M | 166.00M | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 22.99M | 305.10M | 336.00M | 367.00M | 402.30M | |||
| Other Non-Current Assets | 4.44M | 500.00K | 6.20M | 18.60M | 30.30M | |||
| Total Non-Current Assets | 33.73M | 313.50M | 353.30M | 411.40M | 598.60M | |||
| TOTAL ASSETS | 108.53M | 395.60M | 455.50M | 632.70M | 799.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 186.14M | N/A | 0.00 | 68.60M | 600.00K | |||
| Accrued Expenses | 23.74M | 24.20M | 35.00M | 43.20M | 43.50M | |||
| Accounts Payable | 13.37M | 9.80M | 10.80M | 12.20M | 26.30M | |||
| Other Current Liabilities | 4.51M | 3.90M | 8.10M | 13.20M | 16.00M | |||
| Total Current Liabilities | 227.77M | 38.00M | 54.00M | 137.30M | 86.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 167.00M | 178.70M | 166.20M | 218.30M | |||
| Deferred Taxes/Income | 0.00 | 44.20M | 13.90M | 19.10M | 9.60M | |||
| Other Non-Current Liabilities | 38.71M | 52.80M | 57.70M | 72.20M | 174.70M | |||
| Total Non-Current Liabilities | 38.71M | 264.00M | 250.30M | 257.40M | 402.50M | |||
| TOTAL LIABILITIES | 266.48M | 302.00M | 304.30M | 394.70M | 488.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.19B | -936.30M | -870.40M | -766.40M | -666.80M | |||
| Additional Paid In Capital | 1.03B | 1.03B | 1.02B | 1.01B | 979.40M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -638.00K | -600.00K | -600.00K | -600.00K | -600.00K | |||
| Other Shareholders' Equity | 1.43M | 600.00K | -1.00M | -2.80M | -1.20M | |||
| Shares Outstanding | 1.24M | 1.20M | 700.00K | 500.00K | 400.00K | |||
| Tangible Book Value per Share | -145.68 | -176.25 | -264.14 | -258.00 | -228.75 | |||
| Total Shareholders' Equity | -157.96M | 93.60M | 151.10M | 238.00M | 310.80M | |||
| TOTAL LIABILITIES AND EQUITY | 108.53M | 395.60M | 455.50M | 632.70M | 799.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 1.78 | 1.18 | 0.70 | 0.70 | |||
| Current Ratio | 0.33 | 2.16 | 1.89 | 1.61 | 2.33 | |||
| Return On Assets (ROA) | -232.99% | -16.66% | -22.83% | -15.74% | -34.14% | |||
| Return On Equity (ROE) | N/A | -70.41% | -68.83% | -41.85% | -87.84% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD